These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
145 related items for PubMed ID: 3930991
1. Osmotic blood-brain barrier modification: monoclonal antibody, albumin, and methotrexate delivery to cerebrospinal fluid and brain. Neuwelt EA, Barnett PA, McCormick CI, Frenkel EP, Minna JD. Neurosurgery; 1985 Sep; 17(3):419-23. PubMed ID: 3930991 [Abstract] [Full Text] [Related]
2. Effect of osmotic blood-brain barrier disruption on methotrexate pharmacokinetics in the dog. Neuwelt EA, Frenkel EP, Rapoport S, Barnett P. Neurosurgery; 1980 Jul; 7(1):36-43. PubMed ID: 6774280 [Abstract] [Full Text] [Related]
3. Osmotic blood-brain barrier disruption in the posterior fossa of the dog. Neuwelt EA, Glasberg M, Diehl J, Frenkel EP, Barnett P. J Neurosurg; 1981 Nov; 55(5):742-8. PubMed ID: 6796658 [Abstract] [Full Text] [Related]
11. Entry of [3H]norepinephrine, [125I]albumin and Evans blue from blood into brain following unilateral osmotic opening of the blood-brain barrier. Chiueh CC, Sun CL, Kopin IJ, Fredericks WR, Rapoport SI. Brain Res; 1978 Apr 28; 145(2):291-301. PubMed ID: 638788 [Abstract] [Full Text] [Related]
12. Increased delivery of tumor-specific monoclonal antibodies to brain after osmotic blood-brain barrier modification in patients with melanoma metastatic to the central nervous system. Neuwelt EA, Specht HD, Barnett PA, Dahlborg SA, Miley A, Larson SM, Brown P, Eckerman KF, Hellström KE, Hellström I. Neurosurgery; 1987 Jun 28; 20(6):885-95. PubMed ID: 3112602 [Abstract] [Full Text] [Related]
13. Osmotic blood-brain barrier modification and combination chemotherapy: concurrent tumor regression in areas of barrier opening and progression in brain regions distant to barrier opening. Neuwelt EA, Hill SA, Frenkel EP. Neurosurgery; 1984 Sep 28; 15(3):362-6. PubMed ID: 6090973 [Abstract] [Full Text] [Related]
14. Study with positron emission tomography of the osmotic opening of the dog blood-brain barrier for quinidine and morphine. Agon P, Kaufman JM, Goethals P, Van Haver D, Bogaert MG. J Pharm Pharmacol; 1988 Aug 28; 40(8):539-43. PubMed ID: 2907006 [Abstract] [Full Text] [Related]
15. Effects of intracarotid hyperosmolar mannitol in triethyl tin (TET)-induced rat brain edema--preservation of blood-brain barrier (BBB) in TET edema. Inoue T, Nagara H, Kondo A, Fukui M, Tateishi J. Brain Res; 1987 Jun 30; 414(2):309-13. PubMed ID: 3113663 [Abstract] [Full Text] [Related]
17. Effects of adrenal cortical steroids and osmotic blood-brain barrier opening on methotrexate delivery to gliomas in the rodent: the factor of the blood-brain barrier. Neuwelt EA, Barnett PA, Bigner DD, Frenkel EP. Proc Natl Acad Sci U S A; 1982 Jul 30; 79(14):4420-3. PubMed ID: 6289301 [Abstract] [Full Text] [Related]
18. Comparison and evaluation of osmotic blood-brain barrier disruption following intracarotid mannitol and methylglucamine iothalamate. Sage MR, Wilcox J, Evill CA, Benness GT. Invest Radiol; 1982 Jul 30; 17(3):276-81. PubMed ID: 6811497 [Abstract] [Full Text] [Related]